benzoylpaeoniflorin has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Y; Bo, T; Gui, C; Han, L; Li, C; Shi, B; Tian, Y; Wang, X; Zhang, Y | 1 |
1 other study(ies) available for benzoylpaeoniflorin and Liver Dysfunction
| Article | Year |
|---|---|
Selective Inhibition of Organic Cation Transporter 1 by Benzoylpaeoniflorin Attenuates Hepatic Lipid Accumulation through AMPK Activation.
Topics: AMP-Activated Protein Kinases; Humans; Lipids; Liver Diseases; Molecular Docking Simulation; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2 | 2023 |